查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928629

经经皮机械血栓切除导管市场：依技术、应用、最终用户和通路划分，全球预测（2026-2032）

Percutaneous Mechanical Thrombectomy Catheter Market by Technique, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，经皮机械血栓切除导管市场价值将达到 12.3 亿美元，到 2026 年将成长至 13.2 亿美元，到 2032 年将达到 21.5 亿美元，复合年增长率为 8.23%。

关键市场统计数据
基准年 2025 12.3亿美元
预计年份：2026年 13.2亿美元
预测年份 2032 21.5亿美元
复合年增长率 (%) 8.23%

本书全面介绍了经经皮机械血栓切除导管，系统地说明了临床应用、技术进步以及相关人员的策略重点。

经皮机械血栓切除导管已成为介入医学的重要工具，能够以微创的方式快速恢復急性阻塞性疾病的血流。过去十年间，导管设计、抽吸技术和辅助能量模式的改进，拓展了其在冠状动脉、神经血管、週边血管和静脉等多种血管疾病的临床应用。这些装置在多学科诊疗流程中发挥核心作用，及时再灌注对于患者预后至关重要。

临床创新、报销趋势和手术流程如何改变经皮机械血栓切除导管在临床医生中的应用格局

血栓切除导管领域正经历着变革性的转变，这得益于临床创新、手术标准化和不断变化的医疗保险报销模式的共同推动。近年来，器械技术的进步主要集中在透过改进导管尖端几何形状、可调吸力曲线和辅助能量输送来提高血栓捕获率，从而提高首次手术成功率并缩短手术时间。这些技术进步，以及最大限度减少血管操作并优先采用影像导引的精细化手术技巧，正在提高手术安全性并拓展适应症。

从供应链、设备定价、采购和跨境临床合作的角度分析美国不断变化的关税政策在 2025 年的累积影响。

2025年美国关税政策对医疗设备製造商和医疗服务提供者的供应链、采购流程和策略决策产生了连锁反应。某些进口零件和成品医疗设备关税的提高迫使製造商重新评估供应商关係、库存策略和定价模式。这些变化对于资本密集产品线尤其关键，因为这些产品的利润率对投入成本非常敏感，而供应的连续性对于防止临床服务中断至关重要。

基于细分市场的洞察能够揭示设备策略中，不同技术、应用、最终用户和分销管道的差异化采用模式。

了解血栓栓塞的观点情况有助于深入了解医疗设备应用模式和临床价值提案。按技术划分，目前正在研究抽吸、雷射、水解、旋转和超音波增强等方法，每种方法都有不同的操作流程、器械特性和训练要求。抽吸系统强调操作简单、快速清除血栓，而雷射辅助技术则针对特定成分的血栓和钙化病变。水解和旋转平台提供适用于复杂闭塞的机械破碎策略，超音波增强技术旨在增强血栓破碎效果，同时最大限度地减少血管壁的剪切应力。

区域观点：解读美洲、欧洲、中东和非洲以及亚太地区将如何以独特的方式影响临床应用、监管和投资。

区域趋势对全球的监管要求、支付框架和临床实践模式有显着影响。在美洲，监管路径和临床指南通常强调快速采用实证技术，综合医院系统和领先的三级医疗中心往往是早期采用者。该地区的报销框架越来越注重手术结果，从而推动对已被证实能够降低併发症发生率和缩短住院时间的医疗器械的投资。

专注于领先医疗设备製造商的创新轨迹、策略联盟和产品差异化的竞争情报和公司层面洞察

血栓切除导管领域的主要企业正积极推行差异化策略，将技术改进、策略联盟和服务导向产品结合。产品创新着重于提升器械输送性能、增强血栓捕获能力并最大限度减少血管损伤，而商业策略则强调临床医生培训、完善的售后支援以及与现有检查室基础设施的互通性。这些努力旨在减少手术操作的差异性，并展现可重复的临床疗效，而这正是采购委员会所重视的。

为产业领导者提供优化经皮机械血栓切除导管的临床整合、供应链韧性和商业化的实用策略建议

为确保技术的持续应用和业务连续性，产业领导者应优先关注两个关键领域：临床支援和供应链韧性。投资于全面的临床医生培训项目，包括基于模拟的模组和指导，有助于缩短技术应用时间并降低手术结果的差异性。将培训与完善的临床文件和真实世界证据收集相结合，可以帮助机构改善与支付方的合作，并加快内部采购核准。

报告采用严谨的调查方法，清楚阐述了资料来源、检验过程、主要和次要调查方法以及分析框架。

本分析所依据的研究采用了混合方法，整合了质性访谈、文献回顾和结构化专家检验。主要研究包括对介入医师、采购人员和临床计画主任进行深度访谈，以了解他们对器械性能、手术流程和实施障碍的现场观点。此外，我们也咨询了监管和报销专家，从而将临床发现置于当前的政策框架内进行分析。

简明扼要的结论，整合了临床意义、技术趋势、监管考虑以及价值链各相关人员的策略下一步措施。

经皮机械血栓切除导管在临床需求、技术创新和操作复杂性方面都处于关键的交汇点。器械设计和手术技术的进步正在拓展多种血管疾病的治疗选择，而医疗系统和临床医生则需要兼具已证实的临床获益和可预测的操作性能的解决方案。在推动器械从创新走向常规应用的过程中，健全的临床医生培训、可靠的供应链以及循证医学证据的累积至关重要。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章经皮机械血栓切除导管市场（依技术分类）

  • 吸法
  • 雷射
  • 流变
  • 旋转
  • 超音波增强

第九章 经经皮机械血栓切除导管市场（依应用领域划分）

  • 冠状动脉
  • 神经血管
  • 週边血管
  • 静脉

第十章 经经皮机械血栓切除导管市场（依最终用户划分）

  • 门诊手术中心
  • 心臟导管检查室
  • 医院
  • 专科诊所

第十一章 经经皮机械血栓切除导管市场（依通路划分）

  • 直销
  • 透过分销商销售

第十二章经皮机械血栓切除导管市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章经皮机械血栓切除导管市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国经经皮机械血栓切除导管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国经皮机械血栓切除导管市场

16. 中国经皮机械血栓切除导管市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acandis GmbH & Co. KG
  • Argon Medical Devices, Inc.
  • Boston Scientific Corporation
  • Inari Medical, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Penumbra, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-92740D85F07A

The Percutaneous Mechanical Thrombectomy Catheter Market was valued at USD 1.23 billion in 2025 and is projected to grow to USD 1.32 billion in 2026, with a CAGR of 8.23%, reaching USD 2.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.23 billion
Estimated Year [2026] USD 1.32 billion
Forecast Year [2032] USD 2.15 billion
CAGR (%) 8.23%

An authoritative primer on percutaneous mechanical thrombectomy catheters that frames clinical applications, technological evolution, and strategic priorities for stakeholders

Percutaneous mechanical thrombectomy catheters have emerged as pivotal tools within interventional medicine, enabling rapid restoration of blood flow in acute occlusive conditions while minimizing procedural invasiveness. Over the past decade, refinements in catheter design, aspiration technologies, and adjunctive energy modalities have expanded clinical applicability across coronary, neurovascular, peripheral vascular, and venous territories. These devices now play a central role in multidisciplinary care pathways where timely reperfusion is critical to patient outcomes.

Clinicians and hospital administrators alike face mounting pressure to reconcile clinical efficacy with operational efficiency. As a result, device selection is increasingly shaped by procedural versatility, ease of use, and compatibility with existing catheterization lab workflows. At the same time, developers are investing in incremental and disruptive innovations that enhance clot engagement, reduce vessel trauma, and streamline retrieval. The convergence of clinical need, technical innovation, and procedural optimization makes understanding the current landscape essential for product teams, procurement officers, and clinical leaders.

This introduction establishes the framework for a deeper exploration of technological shifts, regulatory and trade influences, segmentation dynamics, regional variations, and competitive positioning. It serves as a foundation for stakeholders seeking to align clinical priorities with strategic investment and operational readiness in environments where rapid decision-making and evidence-based device adoption are paramount.

How disruptive clinical technologies, reimbursement dynamics, and procedural workflows are reshaping the percutaneous mechanical thrombectomy catheter landscape for clinicians

The thrombectomy catheter landscape is undergoing transformative shifts driven by a combination of clinical innovation, procedural standardization, and evolving reimbursement paradigms. Recent iterations of device technology emphasize improved thrombus engagement through refined tip geometries, variable aspiration profiles, and adjunctive energy delivery, which together enhance first-pass success rates and shorten procedure times. These technical advances are complemented by procedural refinements that prioritize minimal vessel manipulation and integrated imaging guidance, thereby improving safety profiles and expanding indications.

Concurrently, multidisciplinary care models are reshaping how thrombectomy devices are deployed. Stroke networks, vascular teams, and acute coronary care pathways are increasingly coordinated to expedite patient triage and device availability. This coordination reduces door-to-device times and encourages adoption of systems that simplify inventory management and device compatibility across treatment settings. Furthermore, payer and hospital reimbursement frameworks are gradually adapting to recognize the value of rapid reperfusion and its downstream impact on patient recovery and resource utilization.

On the commercialization front, manufacturers are pursuing strategic partnerships with device integrators and capital equipment providers to streamline procurement and training. Emphasis on clinician-focused education and procedural simulation is becoming a differentiator, as early adopters seek devices that reduce learning curves and deliver reproducible outcomes. Taken together, these shifts create an environment in which technological performance, procedural efficiency, and ecosystem integration determine the trajectory of device adoption and long-term clinical impact.

Analyzing the cumulative effects of evolving United States tariff policies in 2025 on supply chains, device pricing, procurement, and cross-border clinical collaborations

The tariff environment in the United States during 2025 has had a cascading effect on supply chains, procurement processes, and the strategic calculus of device manufacturers and healthcare providers. Elevated duties on certain imported components and finished medical devices have prompted manufacturers to reassess vendor relationships, inventory strategies, and pricing models. These shifts are particularly relevant for capital-intensive product lines where margins are sensitive to input costs and where supply continuity is essential for maintaining uninterrupted clinical services.

Manufacturers have responded through a combination of nearshoring, supplier diversification, and component reengineering to mitigate tariff exposure. Nearshoring initiatives prioritize regional suppliers with shorter lead times and more predictable logistics, which can reduce exposure to tariff fluctuations and maritime bottlenecks. At the same time, firms are optimizing bill-of-materials composition to limit tariff-classified inputs or to substitute domestically sourced alternatives where clinically and technically feasible.

Healthcare providers are adapting procurement strategies to preserve access to critical devices without compromising clinical protocols. Group purchasing organizations and integrated health systems are renegotiating supply agreements and exploring long-term contracts to stabilize pricing and ensure reliable delivery. In addition, clinical teams are collaborating closely with supply chain and finance stakeholders to prioritize device utilization based on procedural urgency and comparative clinical benefits. Overall, the tariff-driven adjustments in 2025 have underscored the importance of supply chain resilience and cross-functional planning for sustaining clinical capability in high-acuity settings.

Segmentation-driven insights that reveal differentiated adoption patterns across technique, application, end user, and distribution channels for device strategy

Understanding segmentation offers critical perspective on device adoption patterns and clinical value propositions. Based on technique, studies examine aspiration, laser, rheolytic, rotational, and ultrasound enhanced approaches, each of which carries distinct procedural workflows, device profiles, and training requirements. Aspiration systems emphasize simplicity and rapid extraction, laser-assisted methods target specific thrombus compositions and calcified lesions, rheolytic and rotational platforms deliver mechanical fragmentation strategies suited to complex occlusions, and ultrasound enhanced technologies seek to augment clot disruption while minimizing shear stress on vessel walls.

Turning to application, analysis covers coronary artery, neurovascular, peripheral vascular, and venous interventions, where anatomical complexity, vessel diameter, and collateral circulation drive device selection. Coronary procedures demand low-profile, high-precision catheters designed for tortuous coronary anatomy, while neurovascular interventions prioritize atraumatic tips and navigability to reach distal occlusions. Peripheral vascular uses require devices capable of managing larger thrombus burdens and longer lesion lengths, whereas venous applications often focus on reducing thrombus burden while preserving valvular function.

End user segmentation differentiates ambulatory surgical centers, cardiac catheterization laboratories, hospitals, and specialty clinics, reflecting variation in procedural volume, credentialing, and capital equipment access. Distribution channel distinctions between direct sales and distributor sales influence customer engagement models, training delivery, and post-sale service. Each segmentation axis informs commercialization tactics, clinical education programs, and product development priorities, and together they enable more nuanced planning for rollout, adoption, and long-term clinical integration.

Regional perspectives decoding how the Americas, Europe Middle East & Africa, and Asia-Pacific regions uniquely influence clinical adoption, regulation, and investment

Regional dynamics exert a pronounced influence on regulatory requirements, payer frameworks, and clinical practice patterns across the globe. In the Americas, regulatory pathways and clinical guidelines often emphasize rapid adoption of evidence-based technologies, supported by consolidated hospital systems and advanced tertiary centers that serve as early adopters. Reimbursement frameworks in the region increasingly recognize procedural outcomes, which encourages investments in devices that demonstrably reduce complication rates and length of stay.

In Europe, Middle East & Africa, regulatory harmonization efforts coexist with diverse national reimbursement mechanisms, leading to heterogeneous adoption environments. High-volume vascular centers and specialized neurovascular hubs drive innovation uptake in urban settings, while broader access considerations and cost-sensitive purchasing decisions shape distribution strategies across varied healthcare markets. Regulatory emphasis on clinical evidence and post-market surveillance further influences how manufacturers prioritize clinical studies and real-world evidence generation.

In the Asia-Pacific region, rapid infrastructure expansion, rising procedural volumes, and increasing investment in tertiary care facilities contribute to accelerated device adoption. Local manufacturing capabilities and strategic partnerships frequently play a role in reducing procurement lead times and aligning products with regional clinical practices. Across all regions, the interplay between clinical need, regulatory expectations, and procurement dynamics dictates how devices move from innovation to routine practice, thereby shaping global adoption trajectories and commercial approaches.

Competitive intelligence and company-level insights spotlighting innovation trajectories, strategic partnerships, and product differentiation among leading device manufacturers

Leading companies in the thrombectomy catheter space are pursuing differentiated strategies that combine technological refinement with strategic partnerships and service-oriented offerings. Product innovation centers on improving device deliverability, enhancing thrombus engagement, and minimizing vessel trauma, while commercial strategies emphasize clinician training, robust post-market support, and interoperability with existing lab infrastructure. These combined efforts aim to lower procedural variability and to demonstrate reproducible clinical outcomes that matter to purchasing committees.

Strategic collaborations between device manufacturers and hospital systems, imaging firms, and procedural training organizations are becoming more prevalent. Such alliances help accelerate clinical adoption by offering bundled solutions that encompass devices, training, and digital tools for procedural planning and outcome tracking. In parallel, firms are investing in evidence generation through registries and investigator-initiated studies to build clinical credibility and to address payers' evidence requirements.

Competition is also driving selective differentiation through product portfolios that target specific clinical niches, such as distal neurovascular applications or high-burden peripheral thrombus. Companies that combine clinical insight with flexible commercial models and strong service commitments tend to gain preferred status among interventional teams. Ultimately, sustainable competitive advantage is built on demonstrable clinical performance, predictable supply, and an integrated approach to clinician enablement and post-sale support.

Actionable strategic recommendations for industry leaders to optimize clinical integration, supply resilience, and commercialization of percutaneous mechanical thrombectomy catheters

Industry leaders should prioritize a dual focus on clinical enablement and supply chain resilience to ensure sustainable adoption and operational continuity. Investing in comprehensive clinician training programs, including simulation-based modules and proctoring, shortens implementation timelines and reduces variability in procedural outcomes. By coupling training with robust clinical documentation and real-world evidence collection, organizations can accelerate payer engagement and internal procurement approvals.

On the supply side, establishing multi-source supplier networks and nearshoring key components can reduce exposure to trade disruptions and tariff volatility. Collaborative planning with procurement partners, including long-term contracts and strategic stock buffers for high-use items, will mitigate the risk of critical shortages. Additionally, incorporating modular design principles that allow certain components to be sourced regionally can provide tariff flexibility without compromising clinical performance.

Commercially, differentiating through integrated solutions that combine devices with digital procedural support and outcome-tracking tools strengthens value propositions for health systems. Manufacturers and distributors should also consider flexible pricing and training bundles that align with different end-user environments, from ambulatory surgical centers to high-volume hospital networks. Finally, engaging early with regulatory agencies and payer stakeholders to clarify evidentiary expectations will streamline product introductions and support broader clinical integration.

Robust research methodology outlining data sources, validation processes, primary and secondary research approaches, and analytical frameworks used in the report

The research underlying this analysis employed a mixed-methods approach that integrates primary qualitative interviews, secondary literature synthesis, and structured expert validation. Primary research included in-depth interviews with practicing interventionalists, procurement leaders, and clinical program directors to capture frontline perspectives on device performance, procedural workflows, and adoption barriers. These conversations were complemented by consultations with regulatory and reimbursement specialists to contextualize the clinical insights within prevailing policy frameworks.

Secondary research drew on peer-reviewed clinical studies, guideline statements, and procedural registries to map evidence trends and standard-of-care shifts. Attention was paid to device-specific performance characteristics reported in clinical evaluations, as well as to safety signals and user-reported advantages that influence selection. The research team synthesized these inputs using thematic analysis to identify recurring patterns and to triangulate findings across sources.

Finally, the analysis was validated through expert review panels that included clinicians, supply chain professionals, and commercial strategists. This validation process ensured that conclusions reflect practical realities across diverse healthcare settings and that recommended actions are operationally feasible. Throughout the research cycle, emphasis was placed on transparency of assumptions and on clearly delineating evidence-based insights from expert opinion.

A succinct conclusion synthesizing clinical implications, technology trends, regulatory considerations, and strategic next steps for stakeholders across the value chain

Percutaneous mechanical thrombectomy catheters occupy a critical intersection of clinical need, technical innovation, and operational complexity. Advances in device design and procedural techniques are expanding therapeutic options across multiple vascular territories, while health systems and clinicians seek solutions that combine demonstrated clinical benefit with predictable operational performance. The role of robust clinician training, reliable supply chains, and evidence generation cannot be overstated in moving devices from innovation to routine practice.

Regulatory landscapes and regional procurement dynamics further shape adoption pathways, requiring manufacturers and health systems to adopt context-sensitive strategies. Strategic investments in partnerships, clinical evidence, and distribution models will determine which technologies achieve durable clinical integration. In short, stakeholders who align clinical priorities with pragmatic commercial and supply-side planning will be best positioned to deliver improved patient outcomes and operational efficiencies.

This conclusion underscores the need for coordinated action across clinical, commercial, and supply chain functions to translate device innovation into measurable improvements in patient care. It highlights the imperative for ongoing collaboration between manufacturers, clinicians, and institutional buyers to ensure that device selection and deployment are informed by comprehensive evidence, operational feasibility, and long-term clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Mechanical Thrombectomy Catheter Market, by Technique

  • 8.1. Aspiration
  • 8.2. Laser
  • 8.3. Rheolytic
  • 8.4. Rotational
  • 8.5. Ultrasound Enhanced

9. Percutaneous Mechanical Thrombectomy Catheter Market, by Application

  • 9.1. Coronary Artery
  • 9.2. Neurovascular
  • 9.3. Peripheral Vascular
  • 9.4. Venous

10. Percutaneous Mechanical Thrombectomy Catheter Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Catheterization Laboratories
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Percutaneous Mechanical Thrombectomy Catheter Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales

12. Percutaneous Mechanical Thrombectomy Catheter Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Percutaneous Mechanical Thrombectomy Catheter Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Percutaneous Mechanical Thrombectomy Catheter Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Percutaneous Mechanical Thrombectomy Catheter Market

16. China Percutaneous Mechanical Thrombectomy Catheter Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acandis GmbH & Co. KG
  • 17.6. Argon Medical Devices, Inc.
  • 17.7. Boston Scientific Corporation
  • 17.8. Inari Medical, Inc.
  • 17.9. Johnson & Johnson
  • 17.10. Medtronic plc
  • 17.11. Penumbra, Inc.
  • 17.12. Stryker Corporation
  • 17.13. Teleflex Incorporated
  • 17.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY RHEOLYTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY RHEOLYTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY RHEOLYTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ROTATIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ROTATIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ROTATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ULTRASOUND ENHANCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ULTRASOUND ENHANCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY ULTRASOUND ENHANCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY CORONARY ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY CORONARY ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY CORONARY ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY VENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY VENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 100. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 120. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)